Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients.
Clinical trial NCT04564898 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04564898
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-25
- Primary completion
- 2024-05-29
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.